CCB International had forecast a potential secondary-market re-rating to 60–109 billion yuan, a range the IPO pricing already touched .

DeepSeek's Strategic Investment: $20.8 Million and an AI Partnership

DeepSeek invested 140.8 million yuan (~$20.8 million) in Unitree's IPO as a cornerstone strategic investor, receiving 933,399 shares representing 2.31% of the allocation . The investment is tied to a joint development agreement on AI models for humanoid machines, integrating DeepSeek's large-language-model technology into Unitree's robot platforms .

The strategic rationale is clear: pairing China's leading AI startup with its top humanoid hardware maker creates a full-stack embodied-intelligence play designed to compete with U.S. rivals. The partnership dates back to early 2025, when the companies first announced a cooperative relationship to bring AI into robot products . Both companies now also share the same U.S. regulatory scrutiny — each has been flagged by the Pentagon and congressional committees for alleged ties to the People's Liberation Army .

Financials: Humanoid Revenue Surpasses Quadrupeds

Unitree's financial trajectory reveals a company in rapid transition. Revenue accelerated from 123 million yuan in 2022 to 1.70 billion yuan in 2025 — a compound annual growth rate that reflects the explosion of its humanoid robot business .

2025 full-year highlights:

• Revenue: 1.70 billion yuan (1.699 billion), up from 392 million yuan in 2024
• Net profit: ~278–288 million yuan, up from a loss of 22.1 million yuan in 2022
• Core-business gross margin: 60.13%
• Humanoid robot revenue: 867.8 million yuan, or 51.78% of main business — surpassing quadruped robots (42.25%) for the first time
• Humanoid units shipped: Over 5,500 units in 2025, making Unitree the global leader in humanoid robot unit shipments
• Average humanoid price: Dropped from ~590,000 yuan in early 2025 to ~166,400 yuan by late 2025, reflecting an aggressive price-for-volume strategy

The shift from quadrupeds to humanoids is dramatic. In 2023, humanoid robots contributed just 2.97 million yuan in revenue (1.88% of the total). By the first three quarters of 2025, they accounted for 51.53% . Unitree also sold over 33,000 quadruped robots cumulatively from 2023 to 2025, maintaining the top global market share in that category .

However, momentum moderated in early 2026: first-quarter revenue rose 68.5% YoY to 422.8 million yuan, but profit excluding one-off items fell 52.6% to 40.3 million yuan as R&D and marketing spending increased sharply .

US-China Tensions: The Biggest Risk Factor

Unitree's IPO arrives under an unusually dense set of U.S. restrictions targeting Chinese robotics:

• Pentagon Section 1260H list (June 8, 2026): Unitree was added to the Pentagon's list of "Chinese military companies," barring it from U.S. defense contracts and triggering reputational and supply-chain scrutiny . The Pentagon cited Unitree's indirect ownership by SASAC and its participation in military-civil fusion programs .
• FCC ban on new Chinese robots (July 28, 2026): The Trump administration banned imports of new Chinese-made humanoid and quadruped robots, citing national security risks to critical infrastructure . The ban applies to models not yet authorized for sale in the U.S., while existing models are temporarily exempted .
• US sales exposure: U.S. sales accounted for 13.3% of Unitree's total revenue in 2025 .
• Broader risks: Unitree's prospectus warns that U.S. tariffs, limits on government purchases, export controls, or loss of existing approvals could hurt overseas growth and disrupt supplies of imported components .

The combined effect creates material downside risk for Unitree's international expansion. While the company is shifting its product mix toward humanoids (sold mainly in China and Europe), losing access to its largest single overseas market could pressure growth, particularly as it burns cash on R&D and marketing .

What the Unitree IPO Means for the Robot Sector

As the world's first publicly traded pure-play humanoid robot company, Unitree's 61 billion yuan valuation sets a benchmark for the entire embodied-intelligence sector . The DeepSeek partnership signals that the next phase of competition in robotics will be defined by the integration of advanced AI models with affordable, high-volume hardware. Yet the immediate regulatory headwinds from Washington — and the 219x P/E multiple that leaves little room for error — mean Unitree will face intense scrutiny on both commercial and geopolitical fronts from day one of trading.

CCB International had forecast a potential secondary-market re-rating to 60–109 billion yuan, a range the IPO pricing already touched .

DeepSeek's Strategic Investment: $20.8 Million and an AI Partnership

DeepSeek invested 140.8 million yuan (~$20.8 million) in Unitree's IPO as a cornerstone strategic investor, receiving 933,399 shares representing 2.31% of the allocation . The investment is tied to a joint development agreement on AI models for humanoid machines, integrating DeepSeek's large-language-model technology into Unitree's robot platforms .

The strategic rationale is clear: pairing China's leading AI startup with its top humanoid hardware maker creates a full-stack embodied-intelligence play designed to compete with U.S. rivals. The partnership dates back to early 2025, when the companies first announced a cooperative relationship to bring AI into robot products . Both companies now also share the same U.S. regulatory scrutiny — each has been flagged by the Pentagon and congressional committees for alleged ties to the People's Liberation Army .

Financials: Humanoid Revenue Surpasses Quadrupeds

Unitree's financial trajectory reveals a company in rapid transition. Revenue accelerated from 123 million yuan in 2022 to 1.70 billion yuan in 2025 — a compound annual growth rate that reflects the explosion of its humanoid robot business .

2025 full-year highlights:

• Revenue: 1.70 billion yuan (1.699 billion), up from 392 million yuan in 2024
• Net profit: ~278–288 million yuan, up from a loss of 22.1 million yuan in 2022
• Core-business gross margin: 60.13%
• Humanoid robot revenue: 867.8 million yuan, or 51.78% of main business — surpassing quadruped robots (42.25%) for the first time
• Humanoid units shipped: Over 5,500 units in 2025, making Unitree the global leader in humanoid robot unit shipments
• Average humanoid price: Dropped from ~590,000 yuan in early 2025 to ~166,400 yuan by late 2025, reflecting an aggressive price-for-volume strategy

The shift from quadrupeds to humanoids is dramatic. In 2023, humanoid robots contributed just 2.97 million yuan in revenue (1.88% of the total). By the first three quarters of 2025, they accounted for 51.53% . Unitree also sold over 33,000 quadruped robots cumulatively from 2023 to 2025, maintaining the top global market share in that category .

However, momentum moderated in early 2026: first-quarter revenue rose 68.5% YoY to 422.8 million yuan, but profit excluding one-off items fell 52.6% to 40.3 million yuan as R&D and marketing spending increased sharply .

US-China Tensions: The Biggest Risk Factor

Unitree's IPO arrives under an unusually dense set of U.S. restrictions targeting Chinese robotics:

• Pentagon Section 1260H list (June 8, 2026): Unitree was added to the Pentagon's list of "Chinese military companies," barring it from U.S. defense contracts and triggering reputational and supply-chain scrutiny . The Pentagon cited Unitree's indirect ownership by SASAC and its participation in military-civil fusion programs .
• FCC ban on new Chinese robots (July 28, 2026): The Trump administration banned imports of new Chinese-made humanoid and quadruped robots, citing national security risks to critical infrastructure . The ban applies to models not yet authorized for sale in the U.S., while existing models are temporarily exempted .
• US sales exposure: U.S. sales accounted for 13.3% of Unitree's total revenue in 2025 .
• Broader risks: Unitree's prospectus warns that U.S. tariffs, limits on government purchases, export controls, or loss of existing approvals could hurt overseas growth and disrupt supplies of imported components .

The combined effect creates material downside risk for Unitree's international expansion. While the company is shifting its product mix toward humanoids (sold mainly in China and Europe), losing access to its largest single overseas market could pressure growth, particularly as it burns cash on R&D and marketing .

What the Unitree IPO Means for the Robot Sector

As the world's first publicly traded pure-play humanoid robot company, Unitree's 61 billion yuan valuation sets a benchmark for the entire embodied-intelligence sector . The DeepSeek partnership signals that the next phase of competition in robotics will be defined by the integration of advanced AI models with affordable, high-volume hardware. Yet the immediate regulatory headwinds from Washington — and the 219x P/E multiple that leaves little room for error — mean Unitree will face intense scrutiny on both commercial and geopolitical fronts from day one of trading.